Inhibrx Biosciences spin-off registration effective; distribution May 29, merger with Sanofi May 30

Inhibrx Biosciences, Inc.

Registration statement on Form 10 declared effective by SEC on May 24, 2024.
Distribution of 92% of Inhibrx Biosciences shares to RemainCo holders at 1:4 ratio; effective May 29.
RemainCo merger with Sanofi expected to close May 30, subject to conditions.
When-issued trading under INXBV from May 28; regular-way under INXB from May 30; then INBX from May 31.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.